Liu Zhihua, Zhou Yukun, Zhang Peng, Qin Huanlong
Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Surg Laparosc Endosc Percutan Tech. 2010 Jun;20(3):130-40. doi: 10.1097/SLE.0b013e3181d823df.
Surgical resection has been considered to be the best treatment for hepatocellular carcinoma (HCC). However, in recent years, there has been growing interest in the therapy of radiofrequency ablation (RFA). This meta-analysis is to evaluate the therapeutic effect of those 2 therapeutic methods. Outcomes evaluated were death rate, complications, survival rates, recurrence-free survival rates, and recurrence. Primary authors were contacted to retrieve further information if necessary. There is no significant difference in death rates of the treatment of HCC in the groups of hepatectomy and RFA, although the recurrence of HCC may be lower in the hepatectomy group. In the group of RFA, the recurrence rate in the previous site was higher but was lower in the new area, whereas it seems equal in the extrahepatic area. RFA may have comparable results with surgical resection in patients in the therapeutic effect of ablation for the treatment of HCC, if recurrence of HCC after RFA could be timely detected and effectively treated.
手术切除一直被认为是肝细胞癌(HCC)的最佳治疗方法。然而,近年来,人们对射频消融(RFA)治疗的兴趣日益浓厚。本荟萃分析旨在评估这两种治疗方法的疗效。评估的结果包括死亡率、并发症、生存率、无复发生存率和复发情况。如有必要,会联系第一作者以获取更多信息。肝切除术组和RFA组在HCC治疗的死亡率方面无显著差异,尽管HCC在肝切除术组的复发率可能较低。在RFA组中,先前部位的复发率较高,但在新区域较低,而在肝外区域似乎相当。如果RFA后HCC的复发能够被及时检测并有效治疗,那么在HCC消融治疗的疗效方面,RFA与手术切除可能具有相当的结果。